CPIC 2026 | Youyi Biotech Special Session: Advanced Stem Cell Culture Processes
Apr 19,2026
The 1st China Pharmaceutical Innovation Conference (CPIC), hosted by TONACEA, will be grandly held from July 22 to 24, 2026, at the National Exhibition and Convention Center (Shanghai).
Benchmarking the J.P. Morgan Healthcare Conference, CPIC aims to establish a new paradigm of "Chinese Innovation – Global Translation – Shanghai Transaction." As the "premier window" for global capital and enterprises to gain insight into China's innovation ecosystem, and as the "core hub" for Chinese pharmaceutical companies to upgrade, go global, and connect with the world, CPIC is set to become the definitive barometer for annual investment and collaboration in the global health industry. The conference will feature dozens of dedicated sessions covering numerous hot topics and future directions in health industry innovation investment and globalization.
Stem cell therapies are accelerating their transition from the laboratory to the clinic. Scalable, standardized, and cost-effective cell culture processes are the critical bottleneck determining whether this transition can truly succeed. The "Advanced Stem Cell Culture Processes" special session, co-hosted by Youyi Biotech and TONACEA, will focus on core topics such as large-scale stem cell expansion, serum-free culture systems, bioreactor design, and process scale-up. Leading experts from industry, academia, and research will be invited to share practical experiences and cutting-edge breakthroughs. From July 22 to 24 in Shanghai, we look forward to exploring process solutions for stem cell industrialization with you.
Session Theme | Advanced Stem Cell Culture Processes
Organizers | Youyi Biotech, TONACEA
Venue | Hall 4.2, National Exhibition and Convention Center (Shanghai)
Scan the QR code to register now!
Limited-time early bird tickets at 40% off – grab yours now!!
The overseas registration link will be available soon. Stay tuned!
// 专场议程//
• MSC Culture: From 2D to 3D
Liao Lianming: CSO, Tuohong Biotechnology
• Exosome High-Efficiency Expression Factory Driven by All-Factor Integrated Culture Media
Ali Mohsin: Vice President of R&D, Youyi Biotech
• Roundtable 1: Implementation of Decrees 818 and 828 – Risks and Challenges in the Cell Therapy Supply Chain Under Dual Regulatory Pathways
• Roundtable 2: Compliance and Future Prospects of MSC Cell Therapy
About Youyi Biotech
Suzhou Youyi Biotechnology Co., Ltd. has established a 1,000 m² R&D laboratory and a 2,000 m² GMP production base in Wujiang District, Suzhou. Utilizing internationally leading jet-milling technology, its dry powder production line can produce up to 500 kg per batch, while its liquid filling line has an annual capacity of 700,000 liters. The company has obtained international quality system certifications including ISO9001, CNAS, and ISO13485, and has completed DMF filings for products such as transient transfection kits, immune cell culture media, and MSC cell culture media. With the vision of stably providing high-quality culture media to customers, the company is committed to helping clients achieve increased efficiency and cost reduction.
Its wholly-owned subsidiary, Shanghai Youyi Biotechnology Co., Ltd., was founded in March 2022 and is a national high-tech enterprise focused on providing differentiated serum-free culture media. Since its establishment, it has successfully completed angel and Series A financing rounds, and has been recognized with numerous honors including Chongben Leading Talent Enterprise, Wujiang District Leading Talent Enterprise, Suzhou Gusu Leading Talent Enterprise, National Technology-Based SME, and National High-Tech Enterprise.
About TONACEA
TONACEA is a premier ecosystem platform in China's biomedical innovation sector. With over 20 years of deep engagement in China's innovative drug development, it has grown into a key organizational force driving China's pharmaceutical innovation and serves as a core hub connecting multinational pharmaceutical companies with local innovation.
TONACEA brings together multinational pharmaceutical companies, biotech firms, investment institutions, research institutes, and regulatory experts, establishing a high-end professional network and knowledge-sharing system that covers the entire R&D value chain. Its business encompasses industry summits, technical forums, customized corporate training, media communications, and strategic consulting. With multiple branches across China, TONACEA has built an operational network that extends nationwide. Its official WeChat account and video channel consistently deliver in-depth industry insights, with perspectives frequently cited by investors and media, earning recognition as a trusted authoritative source within the industry.
Follow or Contact Us
Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.
Public Account QR Code
Registration QR Code
Conference Service Hotline
© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.
